D4Ertd22e Inhibitors

D4Ertd22e Inhibitors are a class of chemicals that can indirectly inhibit the functional activity of D4Ertd22e by influencing the cellular processes or signaling pathways it is involved in. These include inhibitors of the PI3K-Akt pathway, such as LY294002, Wortmannin, and Rapamycin, which inhibit the activation of Akt, a key component of this pathway. This inhibition can indirectly decrease the functional activity of D4Ertd22e, which is known to be involved in the PI3K-Akt pathway.

Other D4Ertd22e inhibitors target the MAPK pathway, a signaling route where D4Ertd22e is believed to play a role. These inhibitors, including SB203580, PD98059, and SP600125, halt the functional activity of molecules in the MAPK pathway, which leads to the functional inhibition of D4Ertd22e. Furthermore, inhibitors such as PP2 and Genistein, which inhibit Src family kinases and tyrosine kinases respectively, leads to the functional inhibition of D4Ertd22e is involved in the same cellular processes. Finally, inhibitors like U0126, Akti-1/2, Y-27632, and KN-93target MEK in the MAPK pathway, Akt in the PI3K-Akt pathway, ROCK, and CaMKII respectively.